The competition for top employee talent along with the most recent stock market decline is shaping equity compensation trends in the life sciences sector. The industry faced pressure for nearly two years due to the pandemic and a continuous, unprecedented demand for talent. It is a great time to review the various stock and option grants. Topics we discuss: • The current equity compensation trends • Review of the most popular equity grants such as stock options and RSUs • Changing jobs? Evaluating current & future benefits while negotiating • Maximizing your equity compensation and your financial goals solution This commentary is provided for informational purposes only and should not be construed as investment advice. Any opinions or forecasts contained herein reflect the subjective judgments and assumptions of the authors only and do not necessarily reflect the views of Commonwealth Financial Network. Investment recommendations may be inconsistent with these opinions. Diversification does not ensure a profit or guarantee against a loss. Investing involves risk including possible loss of principal.

0 Comments Sort By